Repository logo
 

GM-CSF targeting in COVID-19: an approach based on fragile foundations.

Published version
Peer-reviewed

Type

Other

Change log

Authors

Kohler, Katharina 
Conway Morris, Andrew  ORCID logo  https://orcid.org/0000-0002-3211-3216

Abstract

Trials of anti-GM-CSF therapies in COVID-19 show divergent results; this may be explained by underlying biology and the fragility of the study findings. Further investigation of the pathophysiology of COVID-19 is required to better target therapies. http://bit.ly/3O1AuIo

Description

Keywords

Humans, COVID-19, Antibodies, Monoclonal, Humanized

Is Part Of

Publisher

European Respiratory Society (ERS)
Sponsorship
MRC (MR/V006118/1)
Academy of Medical Sciences (SGL023\1048)
KK is supported by grants from the Academy of Medical Sciences (SG023\1048) and NIHR Development and Skills Enhancement award (NIHR 302841). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. ACM is supported by a Clinician Scientist Fellowship from the Medical Research Council (MR/V006118/1).